A novel approach to identify non-palpable breast lesions combining fluorescent liposomes and magnetic resonance-guided high intensity focused ultrasound-triggered release

C. Oerlemans; J.F.W Nijsen; M. van Amersfoort; L. van Bloois; E. Heijman; P.R. Luijten; W.P.T.M. Mali; G. Storm

A novel approach to identify non-palpable breast lesions combining fluorescent liposomes and magnetic resonance-guided high intensity focused ultrasound-triggered release

C. Oerlemans
, J.F.W Nijsen
, M. van Amersfoort
, L. van Bloois
, E. Heijman
, P.R. Luijten
, W.P.T.M. Mali
, G. Storm

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	458-464
Number of pages	7
Journal	European Journal of Pharmaceutics and Biopharmaceutics
Volume	77
Issue number	3
Publication status	Published - 2011

Keywords

Econometric and Statistical Methods: General
Geneeskunde (GENK)
Farmacie/Biofarmaceutische wetenschappen (FARM)
Medical technology
Farmacie(FARM)
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid
Biomedische technologie en medicijnen
Pharmacology

Cite this

Oerlemans, C., Nijsen, J. F. W., van Amersfoort, M., van Bloois, L., Heijman, E., Luijten, P. R., Mali, W. P. T. M., & Storm, G. (2011). A novel approach to identify non-palpable breast lesions combining fluorescent liposomes and magnetic resonance-guided high intensity focused ultrasound-triggered release. European Journal of Pharmaceutics and Biopharmaceutics, 77(3), 458-464.

@article{a9b1aa9fc9b64d0986d44f54fecb0ee1,

title = "A novel approach to identify non-palpable breast lesions combining fluorescent liposomes and magnetic resonance-guided high intensity focused ultrasound-triggered release",

keywords = "Econometric and Statistical Methods: General, Geneeskunde (GENK), Farmacie/Biofarmaceutische wetenschappen (FARM), Medical technology, Farmacie(FARM), Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid, Biomedische technologie en medicijnen, Pharmacology",

author = "C. Oerlemans and J.F.W Nijsen and \{van Amersfoort\}, M. and \{van Bloois\}, L. and E. Heijman and P.R. Luijten and W.P.T.M. Mali and G. Storm",

year = "2011",

language = "Undefined/Unknown",

volume = "77",

pages = "458--464",

journal = "European Journal of Pharmaceutics and Biopharmaceutics",

issn = "0939-6411",

publisher = "Elsevier BV",

number = "3",

}

Oerlemans, C, Nijsen, JFW, van Amersfoort, M, van Bloois, L, Heijman, E, Luijten, PR, Mali, WPTM & Storm, G 2011, 'A novel approach to identify non-palpable breast lesions combining fluorescent liposomes and magnetic resonance-guided high intensity focused ultrasound-triggered release', European Journal of Pharmaceutics and Biopharmaceutics, vol. 77, no. 3, pp. 458-464.

A novel approach to identify non-palpable breast lesions combining fluorescent liposomes and magnetic resonance-guided high intensity focused ultrasound-triggered release. / Oerlemans, C.; Nijsen, J.F.W; van Amersfoort, M. et al.
In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 77, No. 3, 2011, p. 458-464.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A novel approach to identify non-palpable breast lesions combining fluorescent liposomes and magnetic resonance-guided high intensity focused ultrasound-triggered release

AU - Oerlemans, C.

AU - Nijsen, J.F.W

AU - van Amersfoort, M.

AU - van Bloois, L.

AU - Heijman, E.

AU - Luijten, P.R.

AU - Mali, W.P.T.M.

AU - Storm, G.

PY - 2011

Y1 - 2011

KW - Econometric and Statistical Methods: General

KW - Geneeskunde (GENK)

KW - Farmacie/Biofarmaceutische wetenschappen (FARM)

KW - Medical technology

KW - Farmacie(FARM)

KW - Geneeskunde(GENK)

KW - Medical sciences

KW - Bescherming en bevordering van de menselijke gezondheid

KW - Biomedische technologie en medicijnen

KW - Pharmacology

M3 - Article

SN - 0939-6411

VL - 77

SP - 458

EP - 464

JO - European Journal of Pharmaceutics and Biopharmaceutics

JF - European Journal of Pharmaceutics and Biopharmaceutics

IS - 3

ER -